DYADIC INTERNATIONAL, INC.

DYAI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017
Revenue $1.3M $758.4K
Cost of Revenue $1.0M $680.2K
Gross Profit $268.2K $78.2K
Gross Margin 20.7% 10.3%
Operating Expenses
Research & Development $2.1M $1.8M
SG&A Expense $4.5M $5.0M
Operating Income $-7.6M $-7.1M
Operating Margin -586.1% -939.7%
Interest Expense
Pretax Income
Income Tax Expense $-1.0M $-66.7K
Net Income $-5.7M $-2.1M
Net Margin -439.4% -281.6%
EPS (Basic) $-0.21 $-0.07
EPS (Diluted) $-0.21 $-0.07
Shares Outstanding (Basic) 26.7M 28.3M
Shares Outstanding (Diluted) 26.7M 28.3M
Dividends Per Share
← Newer Page 2 of 2 Older →